Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get iLink® Corneal Cross-Linking Covered by Aetna CVS Health in Ohio: Complete Prior Authorization and Appeals Guide

Answer Box: Getting iLink® Covered by Aetna CVS Health in Ohio Aetna CVS Health covers epithelium-off corneal cross-linking using the FDA-approved iLink® system for progressive keratoconus, requiring prior authorization with documented disease progression via serial corneal topography. Your fastest path: (1) Gather serial topography showing Kmax progression over 3-6 months,
6 min read

How to Get Helixate (antihemophilic factor, rFVIII) Covered by Aetna CVS Health in Ohio: Complete Prior Authorization and Appeals Guide 2024

Quick Answer: Getting Helixate (antihemophilic factor, rFVIII) Covered by Aetna CVS Health in Ohio Aetna CVS Health requires prior authorization for Helixate (antihemophilic factor, rFVIII) in Ohio. Submit your PA request through your hematologist with complete hemophilia A documentation, including factor VIII levels <1% (severe) or 1-5% (moderate), bleed
5 min read

Renewing Kymriah (Tisagenlecleucel) Approval with Aetna CVS Health in Georgia: Complete Timeline and Documentation Guide

Answer Box: Kymriah Renewal with Aetna CVS Health in Georgia Kymriah (tisagenlecleucel) requires prior authorization renewal through Aetna CVS Health in Georgia based on treatment protocols—typically 1-3 months post-infusion for initial monitoring, then annually or as clinically indicated. Submit renewal documentation via CoverMyMeds portal using the dedicated Tisagenlecleucel Prior
5 min read

Work With Your Doctor to Get Increlex (mecasermin) Approved by Aetna (CVS Health) in Illinois: Provider Collaboration Guide

Answer Box: Getting Increlex (mecasermin) Covered by Aetna (CVS Health) in Illinois Aetna (CVS Health) requires prior authorization for Increlex (mecasermin) in pediatric patients with severe primary IGF-1 deficiency. Success depends on strong provider collaboration: your pediatric endocrinologist must document height ≤3 SD below mean, IGF-1 ≤3 SD below normal,
6 min read

How to Get Cabometyx (Cabozantinib) Covered by Aetna CVS Health in California: Complete Prior Authorization Guide

Quick Answer: Getting Cabometyx Covered by Aetna CVS Health in California Cabometyx (cabozantinib) requires prior authorization from Aetna CVS Health for FDA-approved cancer indications. Your oncologist must submit clinical documentation including diagnosis codes (ICD-10), pathology reports, prior therapy failures, and recent imaging. California law requires decisions within 72 hours for
6 min read

How to Get Nourianz (istradefylline) Covered by Aetna CVS Health in California: Prior Authorization Forms, Timelines, and State Appeal Rights

Answer Box: Getting Nourianz Covered by Aetna CVS Health in California Nourianz (istradefylline) requires prior authorization from Aetna CVS Health for Parkinson's disease OFF episodes. To get approved in California: (1) Submit PA form via Availity portal with documented OFF episodes ≥2 hours/day, concurrent levodopa/carbidopa use,
5 min read

How to Get Exondys 51 (Eteplirsen) Covered by Aetna CVS Health in California: Prior Authorization Guide and Appeals Process

Answer Box: Fast Track to Approval To get Exondys 51 (eteplirsen) covered by Aetna CVS Health in California: Submit prior authorization with genetic testing confirming exon 51 amenable DMD mutation, specialist prescription, baseline functional assessments (6-minute walk test ≥300m), and corticosteroid trial documentation. If denied, file internal appeal within 21
6 min read

How to Get HyperHEP (Hepatitis B Immune Globulin) Covered by Aetna CVS Health in Ohio: Prior Authorization Guide and Appeal Process

Quick Answer: Getting HyperHEP Covered by Aetna CVS Health in Ohio HyperHEP (hepatitis B immune globulin) requires prior authorization from Aetna Better Health of Ohio for post-exposure prophylaxis. Submit via provider portal with exposure documentation, anti-HBs titer <10 mIU/mL, and CDC-compliant timing (within 24 hours ideally). Routine review
6 min read